In clinical research, PRKAA2 has been shown to be associated with susceptibility to type 2 diabetes [15,16], In addition, the high expression of PRKAA2 may predict the poor prognosis of head and neck squamous cell carcinoma [17], colorectal cancer [18], and endometrial cancer [19]. This evidence concerns the gene PRKAA2 and colorectal cancer.